Skip to content

HOTH

Hoth Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.80
−2.22%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-48.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 28, 2025Knie Robb · director, officer: CEO and PresidentA-Award800,000$0.00
Aug 28, 2025Knie Robb · director, officer: CEO and PresidentF-InKind310,744$1.21
Jan 15, 2025Knie Robb · director, officer: CEO and PresidentA-Award93,000$1.55
Jan 15, 2025Knie Robb · director, officer: CEO and PresidentA-Award7,000$1.55
Jan 15, 2025Springer Graig · directorA-Award70,000$1.55
Aug 21, 2024Pavell Jeff · directorA-Award25,000$0.75
Aug 21, 2024Springer Graig · directorA-Award48,000$0.75
Aug 21, 2024Springer Graig · directorA-Award25,000$0.75
Aug 21, 2024Sarnoff David · directorA-Award25,000$0.75
Aug 21, 2024Knie Robb · director, officer: CEO and PresidentA-Award325,000$0.75
Aug 21, 2024Linsley Wayne · directorA-Award25,000$0.75
Aug 19, 2024Knie Robb · director, officer: CEO and PresidentPurchase25,000$0.67
Jan 8, 2024Springer Graig · directorA-Award100,000$1.36
Jan 8, 2024Springer Graig · directorA-Award25,000$1.36
Jan 8, 2024Sarnoff David · directorA-Award25,000$1.36
Jan 8, 2024Pavell Jeff · directorA-Award25,000$1.36
Jan 8, 2024Linsley Wayne · directorA-Award25,000$1.36
Jan 8, 2024Knie Robb · director, officer: CEO and PresidentA-Award225,000$1.36
Jul 18, 2023Sarnoff David · directorA-Award7,500$2.59
Jul 18, 2023Springer Graig · directorA-Award20,000$2.59
Jul 18, 2023Springer Graig · directorA-Award7,500$2.59
Jul 18, 2023Knie Robb · director, officer: CEO and PresidentA-Award40,000$2.59
Jul 18, 2023Pavell Jeff · directorA-Award7,500$2.59
Jul 18, 2023Linsley Wayne · directorA-Award7,500$2.59
Dec 13, 2022Pavell Jeff · directorA-Award5,075$0.00
Sep 20, 2022Knie Robb · director, officer: CEO and PresidentPurchase10,000$0.39
Sep 19, 2022Knie Robb · director, officer: CEO and PresidentPurchase10,000$0.40
Mar 18, 2022Knie Robb · officer: CEO and PresidentA-Award500,000$0.00
Mar 18, 2022Johns Stefanie · officer: Chief Scientific OfficerA-Award250,000$0.00
Mar 18, 2022Sarnoff David · director: A-Award40,000$0.00
Institutional positioning

13F filings over the trailing two quarters

New 10Increased 8Reduced 9Sold out 4
FilerActionSharesFiled
VANGUARD CAPITAL MANAGEMENT LLCIncreased683,291Aug 13, 2026
JANE STREET GROUP, LLCNew Position219,316Aug 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased214,244May 15, 2026
UBS Group AGIncreased211,304Aug 13, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced195,982Aug 12, 2026
UBS GROUP AGIncreased157,977May 5, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position129,691May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position84,318May 8, 2026
VANGUARD FIDUCIARY TRUST COUnchanged84,318Aug 13, 2026
STATE STREET CORPUnchanged63,939Aug 7, 2026
STATE STREET CORPUnchanged63,939May 15, 2026
NORTHERN TRUST CORPUnchanged42,054May 14, 2026
LPL Financial LLCNew Position41,029Aug 7, 2026
LIDO ADVISORS, LLCIncreased39,000May 13, 2026
NORTHERN TRUST CORPReduced38,724Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2025